GLP-1
Managing GLP-1 nausea without quitting
Most patients can prevent the worst of it with timing, hydration, and the right titration. Here's the playbook our clinicians use.
May 2, 2026 · 5 min read
Peptides
The 2026 peptide landscape: what the PCAC review changes
Several research peptides came off FDA Category 2 in April 2026. What that means for your protocol — and what stays the same.
April 22, 2026 · 7 min read
Men's Health
TRT vs. enclomiphene: which one actually fits your goals?
If your testosterone is low, you have two real options — and the right pick depends less on your numbers than on what you want your body to keep doing.
May 22, 2026 · 6 min read
Longevity
What NAD+ actually does (and what it doesn't)
The biology is real. The marketing has gotten ahead of the data. We separate the two so you can decide if it's worth your time.
April 11, 2026 · 8 min read
Sexual Wellness
Talking to your partner about desire — and PT-141
A clinician's script for an honest conversation when the issue isn't attraction, it's biology.
March 30, 2026 · 5 min read
Behind the Care
How we screen the providers who care for you
Board certification is the floor, not the ceiling. A look inside our hiring bar and why it matters for your outcomes.
March 18, 2026 · 4 min read
Men's Health
TRT vs. enclomiphene: which low-T treatment fits you
Both raise testosterone. Only one preserves fertility and your body's own production. Here's how our clinicians decide between them.
May 20, 2026 · 6 min read
Newsletter
One short note a month. Worth the open.
The studies that actually changed our protocols, written for humans. Unsubscribe anytime.